Skip Navigation Skip to main content
  • Warning Signs
  • Volunteer
  • Donate
return to American Heart Association Newsroom
  • Heart Attack And Stroke Symptoms
  • Volunteer
  • Donate
Newsroom
    • News Media Embargoed Access
    • Login to Password Protected Newsroom
    • Apply for Embargoed Access
    • Embargo Policy and Guidelines
    • American Heart Association Fact Sheets
    • Boilerplates
    • Copyright Permissions
    • Glossary of Scientific Terms
    • Linking Policy
    • Scientific Statements/Guidelines
    • Scientific Publications: Purposes-Processes
    • Statistics
    • Multimedia Resources
    • Animation/Video
    • Images/Graphics
    • Audio
    • Usage Policy
    • Connect With Us
    • Media Contacts
    • Consumer/Media Connections
  • Twitter
  • Facebook
  • YouTube
  • RSS
  • Email Alerts
  1. Newsroom
  2. Search News Releases
  3. Un estilo de vida saludable combinado con los nuevos medicamentos para la diabetes redujo el riesgo cardiovascular
Categories: Heart News, Foreign Language News Releases, Scientific Conferences & Meetings
|
Published: November 03, 2025

Un estilo de vida saludable combinado con los nuevos medicamentos para la diabetes redujo el riesgo cardiovascular

Sesiones Científicas de 2025 de la American Heart Association, póster del resumen MP511
facebook Facebook
twitter Twitter
facebook LinkedIn
facebook Email
facebook Print

Related Images

Previous Slide Next Slide

Tirzepatide injection

Tirzepatide is a GIP and GLP-1 receptor agonist. Prescribed uses include Type-2  diabetes, overweight/obesity and some forms of sleep apnea.

copyright American Heart Association

Download (169.9 kB)
Tirzepatide injection

Tirzepatide injection

Tirzepatide is a GIP and GLP-1 receptor agonist. Prescribed uses include Type-2  diabetes, overweight/obesity and some forms of sleep apnea.

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (169.9 kB) File Permalink

high-dose semaglutide injection pens on table

copyright American Heart Association

Download (1.0 MB)
high-dose semaglutide injection pens on table

high-dose semaglutide injection pens on table

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (1.0 MB) File Permalink

scale weight check

Close up of a scale weight

copyright American Heart Association

Download (36.6 kB)
scale weight check

scale weight check

Close up of a scale weight

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (36.6 kB) File Permalink

Prepping for blood test

Prepping the patient to draw blood for  cholesterol and glucose tests.

copyright American Heart Association

Download (632.0 kB)
Prepping for blood test

Prepping for blood test

Prepping the patient to draw blood for  cholesterol and glucose tests.

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (632.0 kB) File Permalink

American Heart Association Scientific Sessions Logo

copyright American Heart Association

Download (270.2 kB)
American Heart Association Scientific Sessions Logo

American Heart Association Scientific Sessions Logo

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (270.2 kB) File Permalink
  • Tirzepatide injection
  • high-dose semaglutide injection pens on table
  • scale weight check
  • Prepping for blood test
  • American Heart Association Scientific Sessions Logo

Related Video

Previous Slide Next Slide

Dr. Ndumele on SS25 MP511 diabetes risk and GLP1 use

Chiadi E. Ndumele, M.D., Ph.D., FAHA, chair of the American Heart Association’s Council on Lifestyle and Cardiometabolic Health, who is also the director of Obesity and Cardiometabolic Research at Johns Hopkins School of Medicine.

Transcript (txt)

News release

copyright American Heart Association

Download (118.7 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Ndumele on SS25 MP511 diabetes risk and GLP1 use

Chiadi E. Ndumele, M.D., Ph.D., FAHA, chair of the American Heart Association’s Council on Lifestyle and Cardiometabolic Health, who is also the director of Obesity and Cardiometabolic Research at Johns Hopkins School of Medicine.

Transcript (txt)

News release

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (118.7 MB) File Permalink

Dr. Ndumele on SS25 MP511 GLP1 therapies and CVD

Chiadi E. Ndumele, M.D., Ph.D., FAHA, chair of the American Heart Association’s Council on Lifestyle and Cardiometabolic Health, who is also the director of Obesity and Cardiometabolic Research at Johns Hopkins School of Medicine.

Transcript (txt)

News release

copyright American Heart Association

Download (96.6 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Ndumele on SS25 MP511 GLP1 therapies and CVD

Chiadi E. Ndumele, M.D., Ph.D., FAHA, chair of the American Heart Association’s Council on Lifestyle and Cardiometabolic Health, who is also the director of Obesity and Cardiometabolic Research at Johns Hopkins School of Medicine.

Transcript (txt)

News release

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (96.6 MB) File Permalink

Dr. Ndumele on SS25 MP511 GLP1 therapies impact

Chiadi E. Ndumele, M.D., Ph.D., FAHA, chair of the American Heart Association’s Council on Lifestyle and Cardiometabolic Health, who is also the director of Obesity and Cardiometabolic Research at Johns Hopkins School of Medicine.

Transcript (txt)

News release

copyright American Heart Association

Download (96.2 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Ndumele on SS25 MP511 GLP1 therapies impact

Chiadi E. Ndumele, M.D., Ph.D., FAHA, chair of the American Heart Association’s Council on Lifestyle and Cardiometabolic Health, who is also the director of Obesity and Cardiometabolic Research at Johns Hopkins School of Medicine.

Transcript (txt)

News release

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (96.2 MB) File Permalink

Dr. Ndumele on SS25 MP511 study limitations-next steps

Chiadi E. Ndumele, M.D., Ph.D., FAHA, chair of the American Heart Association’s Council on Lifestyle and Cardiometabolic Health, who is also the director of Obesity and Cardiometabolic Research at Johns Hopkins School of Medicine.

Transcript (txt)

News release

copyright American Heart Association

Download (92.3 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Ndumele on SS25 MP511 study limitations-next steps

Chiadi E. Ndumele, M.D., Ph.D., FAHA, chair of the American Heart Association’s Council on Lifestyle and Cardiometabolic Health, who is also the director of Obesity and Cardiometabolic Research at Johns Hopkins School of Medicine.

Transcript (txt)

News release

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (92.3 MB) File Permalink

Dr. Ndumele on SS25 MP511 potential GLP1 impact in broader population

Chiadi E. Ndumele, M.D., Ph.D., FAHA, chair of the American Heart Association’s Council on Lifestyle and Cardiometabolic Health, who is also the director of Obesity and Cardiometabolic Research at Johns Hopkins School of Medicine.

Transcript (txt)

News release

copyright American Heart Association

Download (54.8 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Ndumele on SS25 MP511 potential GLP1 impact in broader population

Chiadi E. Ndumele, M.D., Ph.D., FAHA, chair of the American Heart Association’s Council on Lifestyle and Cardiometabolic Health, who is also the director of Obesity and Cardiometabolic Research at Johns Hopkins School of Medicine.

Transcript (txt)

News release

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (54.8 MB) File Permalink

Dr. Ndumele on SS25 MP511 LE 8 optimal health

Chiadi E. Ndumele, M.D., Ph.D., FAHA, chair of the American Heart Association’s Council on Lifestyle and Cardiometabolic Health, who is also the director of Obesity and Cardiometabolic Research at Johns Hopkins School of Medicine.

Transcript (txt)

News release

copyright American Heart Association

Download (33.9 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Ndumele on SS25 MP511 LE 8 optimal health

Chiadi E. Ndumele, M.D., Ph.D., FAHA, chair of the American Heart Association’s Council on Lifestyle and Cardiometabolic Health, who is also the director of Obesity and Cardiometabolic Research at Johns Hopkins School of Medicine.

Transcript (txt)

News release

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (33.9 MB) File Permalink
  • Dr. Ndumele on SS25 MP511 diabetes risk and GLP1 use
  • Dr. Ndumele on SS25 MP511 GLP1 therapies and CVD
  • Dr. Ndumele on SS25 MP511 GLP1 therapies impact
  • Dr. Ndumele on SS25 MP511 study limitations-next steps
  • Dr. Ndumele on SS25 MP511 potential GLP1 impact in broader population
  • Dr. Ndumele on SS25 MP511 LE 8 optimal health
AHA Logo
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.
CLOSE PROCEED